SABRINA HUFFMAN: Open Payments
NPI 1366720047 · PRINCETON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$905 in 59 payments from 12 companies in 2025. Trend: 2023 $1,574 · 2024 $1,404 · 2025 $905
Food & beverage: $905
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 21 | $311 |
| ABBVIE INC. | 13 | $151 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $102 |
| Lilly USA, LLC | 4 | $75 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $64 |
| Abbott Laboratories | 3 | $60 |
| Exact Sciences Corporation | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $20 |
Products named: Ozempic, Kerendia, VRAYLAR, MOUNJARO, XIFAXAN, Rybelsus, FREESTYLE LIBRE 2, QULIPTA.
Industry payments across WV — which companies pay providers there.
